Research Article
Molecular Docking Assessment of Efficacy of Different Clinically Used Arsenic Chelator Drugs
Table 1
Organs affected by arsenic and the most abundant protein(s) in that organ.
| Affected organ by arsenic | Abundant protein of the organ |
| Skin [18] | Collagen | Heart muscle [19] | Lactate dehydrogenase (LDH) | Reproduction, carcinogenicity [20] | Estrogen receptor alpha (ER-α) | Liver [21] | Thioredoxin reductase (TDR) | Liver [22] | Glutathione reductase (GTH) | Energy metabolism in all cells [23] | Pyruvate dehydrogenase (PDH) | Cytoskeletal structure [24] | Tubulin | Cytoskeletal structure [25] | Actin | Blood (serum) [16, 26] | Albumin | Liver, kidney and brain [17, 21, 26] | Spermine and spermidine |
|
|